[Immunologic aspects in urologic tumors].
D000017:ABO Blood-Group System; D000951:Antigens, Neoplasm; D001500:BCG Vaccine / Q000627:therapeutic use; D002272:Carcinoembryonic Antigen / Q000032:analysis; D006063:Chorionic Gonadotropin / Q000032:analysis; D006801:Humans; D007680:Kidney Neoplasms / Q000276:immunology; D008297:Male; D011379:Prognosis; D013736:Testicular Neoplasms / Q000276:immunology; D014165:Transfer Factor / Q000627:therapeutic use; D001749:Urinary Bladder Neoplasms / Q000276:immunology; D014571:Urologic Neoplasms / Q000276:immunology*; D000509:alpha-Fetoproteins / Q000032:analysis
D000017:ABO Blood-Group System; D000951:Antigens, Neoplasm; D001500:BCG Vaccine; D002272:Carcinoembryonic Antigen; D006063:Chorionic Gonadotropin; D014165:Transfer Factor; D000509:alpha-Fetoproteins
Immunologische Aspekte bei urologischen Tumoren.